drugset / Trial / NCT01853020
Cannabinoids and Cerebellar-Motor Functioning
RandomizedCrossoverQuadruple-blindOther
Summary
The purpose of this study is to characterize the dose-related effects of delta-9-tetrahydrocannabinol (∆9-THC) in healthy individuals on cerebellum-dependent motor functions.
Timeline
- Start
- 2012-12
- Primary completion
- 2015-04-07
- Completion
- 2015-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | delta-9-tetrahydrocannabinol | Other / unclassified | 0.0015 mg/kg | Intravenous |
| Comparator | delta-9-tetrahydrocannabinol | Other / unclassified | 0.015 mg/kg | Intravenous |
| Comparator | delta-9-tetrahydrocannabinol | Other / unclassified | 0.03 mg/kg | Intravenous |